Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR1 | Q9BXC0 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | PIK3CG | P48736 | 7/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.40 |
| ▸ | PNP | P00491 | 2/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.39 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.39 |
| ▸ | BRAF | P15056 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11610799 | 0.85 | DPP4 (0.44) | DPP4PIK3CGPIK3CDPNPPDPK1 | |
| SCHEMBL637361 | 0.84 | PDE4D (0.50) | HCAR1PIK3CGPOLBPIK3CDPNP | |
| SCHEMBL1286959 | 0.83 | HCAR1 (0.49) | HCAR1DPP4PIK3CGRECQLPOLB | |
| SCHEMBL1286947 | 0.81 | MAPK1 (0.51) | HCAR1DPP4PIK3CGPIK3CDPNP | |
| SCHEMBL21768327 | 0.80 | HCAR1 (0.49) | HCAR1PIK3CGRECQLPOLBPNP | |
| Hydrochloric Acid SCHEMBL21799343 | 0.80 | MAPK1 (0.50) | HCAR1DPP4PIK3CGPIK3CDPNP | |
| SCHEMBL1286923 | 0.77 | GSR (0.36) | HCAR1DPP4PIK3CGRECQLPOLB | |
| SCHEMBL17186410 | 0.76 | TNF (0.49) | DPP4PNPPDE4APDE4BPDE4C | |
| SCHEMBL1286944 | 0.75 | PNP (0.38) | DPP4POLBPIK3CDPNPPDE4A | |
| Hydrochloric Acid SCHEMBL17186309 | 0.75 | TNF (0.48) | DPP4PNPPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3616687-B1 | PREPARATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFLAMMATORY INFECTIOUS DISEASES | Lovtsov Valentin Vyacheslavovich (RU) | 2023-11-29 | — | — | EP | disclosed |
| CN-116133654-A | Methods and compositions for treating fungal infections | 纽库利私人有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-115991659-A | Method and product suitable for detecting content of chlorobenzoguanidine in veterinary drug preparation | 北京维德维康生物技术有限公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-3701942-A1 | SOLUBILIZATION OF CHLORHEXIDINE BASE, ANITSEPTIC COMPOSITION AND DISINFECTANT COMPOSITION | The Limited Liability Company "Sun Systems" (RU) | 2020-09-02 | — | — | EP | disclosed |
| US-20200206165-A1 | SOLUBILIZATION OF CHLORHEXIDINE BASE, ANTISEPTIC OR DISINFECTANT COMPOSITIONS | LIMITED LIABILITY COMPANY "SUN SYSTEMS" [RU/RU] (RU) | 2020-07-02 | — | — | US | disclosed |
| EP-3616687-A2 | PREPARATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFLAMMATORY INFECTIOUS DISEASES | Lovtsov, Valentin Vyacheslavovich (RU) | 2020-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206165-A1 | SOLUBILIZATION OF CHLORHEXIDINE BASE, ANTISEPTIC OR DISINFECTANT COMPOSITIONS | POLR1C, POLH, ADAR | HCAR1 566/4885DPP4 1488/4885PIK3CG 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.